0

BW A4C

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP106328578
CAS106328-57-8
Structure
MDL NumberMFCD00869694
Molecular Weight283.32
InChI KeyCEUDWZXMLMKPNN-SOFGYWHQSA-N
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL
Assay≥98% (HPLC)
Colorwhite
MP79.3-80.1 °C (lit.)
Size5MG, 25MG
Storage Conditions2-8°C
1

BW A4C and Other Hydroxamic Acids Are Potent Inhibitors of Linoleic Acid 8R-dioxygenase of the Fungus Gaeumannomyces Graminis

I D Brodowsky, M Hamberg, E H Oliw

Eur J Pharmacol. 1994 Mar 11;254(1-2):43-7.

PMID: 8206115

1

Failure of the Inhibition of Rat Gastric Mucosal 5-lipoxygenase by Novel Acetohydroxamic Acids to Prevent Ethanol-Induced Damage

N K Boughton-Smith, B J Whittle

Br J Pharmacol. 1988 Sep;95(1):155-62.

PMID: 3146394

1

Selective 5-lipoxygenase Inhibitor BW A4C Does Not Influence Progression of Tissue Injury in a Canine Model of Regional Myocardial Ischaemia and Reperfusion

M P Maxwell, C Marston, M R Hadley, J A Salmon, L G Garland

J Cardiovasc Pharmacol. 1991 Apr;17(4):539-45.

PMID: 1711618

1

Selective Inhibition of Arachidonate 5-lipoxygenase by Novel Acetohydroxamic Acids: Effects on Acute Inflammatory Responses

G A Higgs, R L Follenfant, L G Garland

Br J Pharmacol. 1988 Jun;94(2):547-51.

PMID: 2840161

1

The Effects of a 5-lipoxygenase Inhibitor, BW A4C, on the Acute Response to Inhaled PAF in Man

D A Spencer, A P Sampson, J M Evans, L G Garland, P J Piper, J F Costello

Ann N Y Acad Sci. 1991;629:430-1.

PMID: 1952568

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode